Connect with us

Health

Top in hem/onc: Checkpoint inhibitor indications, loneliness of childhood cancer survivors – Healio

Last week, an FDA panel voted against maintaining a gastric cancer indication for pembrolizumab and a hepatocellular carcinoma indication for nivolumab. It was…

Published

on

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Last week, an FDA panel voted against maintaining a gastric cancer indication for pembrolizumab and a hepatocellular carcinoma indication for nivolumab. It was the top story in hematology/oncology.
Another top story revealed childhood cancer survivors have an elevated risk for feelings of loneliness due to isolation during their cancer experience….

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending